已收盤 09-19 16:00:00 美东时间
-0.023
-58.87%
Benchmark analyst Bruce Jackson reiterates Biofrontera (NASDAQ:BFRI) with a Buy and maintains $7 price target.
08-16 21:49
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-16 21:48
Biofrontera Shares Are Trading Higher. The Company Reported Q2 Financial Result...
08-15 22:14
Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a B...
08-15 04:30
Biofrontera shares are trading higher after the company launched the RhodoLED X...
06-24 20:33
The RhodoLED XL is approved by the FDA in combination with Ameluz® (aminolevulinic acid hydrochloride) topical gel, 10% for photodynamic therapy (PDT) of actinic keratoses of mild-to-moderate severity on the face
06-24 20:31